{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:26:57Z","timestamp":1760016417529},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:00:00Z","timestamp":1410134400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-1947-8-299","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T05:01:04Z","timestamp":1410152464000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Anup","family":"Kasi Loknath Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dakhil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Teeka Satyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisreen","family":"Haideri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,8]]},"reference":[{"key":"2926_CR1","first-page":"832","volume":"89","author":"L Rosinol","year":"2004","unstructured":"Rosinol L, Cibeira MT, Blade J, Esteve J, Aymerich M, Rozman M, Segarra M, Cid MC, Filella X, Montserrat E: Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica. 2004, 89: 832-836.","journal-title":"Haematologica"},{"key":"2926_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 2013, 63: 11-30.","journal-title":"CA Cancer J Clin"},{"key":"2926_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeldis J, Siegel D, Crowley J, Barlogie B: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999, 341: 1565-1571.","journal-title":"N Engl J Med"},{"key":"2926_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1182\/blood-2011-03-341669","volume":"118","author":"PM Fayers","year":"2011","unstructured":"Fayers PM, Palumbo A, Hulin C, Waage A, Wijermans P, Beksac M, Bringhen S, Mary JY, Gimsing P, Termorshuizen F, Haznedar R, Caravita T, Moreau P, Turesson I, Musto P, Benboubker L, Schaafsma M, Sonneveld P, Facon T: Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood. 2011, 118: 1239-1247.","journal-title":"Blood"},{"key":"2926_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","volume":"124","author":"R Soutar","year":"2004","unstructured":"Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, Samson D: Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004, 124: 717-726.","journal-title":"Br J Haematol"},{"key":"2926_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/bjc.1995.26","volume":"71","author":"LY Shih","year":"1995","unstructured":"Shih LY, Dunn P, Leung WM, Chen WJ, Wang PN: Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer. 1995, 71: 128-133.","journal-title":"Br J Cancer"},{"key":"2926_CR7","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","volume":"85","author":"C Alexiou","year":"1999","unstructured":"Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, Arnold W: Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999, 85: 2305-2314.","journal-title":"Cancer"},{"key":"2926_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1600-0609.2004.00331.x","volume":"73","author":"G Damaj","year":"2004","unstructured":"Damaj G, Mohty M, Vey N, Dincan E, Bouabdallah R, Faucher C, Stoppa AM, Gastaut JA: Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center. Eur J Haematol. 2004, 73: 402-406.","journal-title":"Eur J Haematol"},{"key":"2926_CR9","first-page":"609","volume":"87","author":"A Alegre","year":"2002","unstructured":"Alegre A, Granda A, Martinez-Chamorro C, Diaz-Mediavilla J, Martinez R, Garcia-Larana J, Lahuerta JJ, Sureda A, Blade J, de la Rubia J, Fernandez-Ranada JM, Miguel JS: Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry. Haematologica. 2002, 87: 609-614.","journal-title":"Haematologica"},{"key":"2926_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1600-0609.2005.00531.x","volume":"75","author":"E Terpos","year":"2005","unstructured":"Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL, Rahemtulla A, Samson D, Apperley JF: Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma. Eur J Haematol. 2005, 75: 376-383.","journal-title":"Eur J Haematol"},{"key":"2926_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3109\/10428190109099330","volume":"42","author":"A Avigdor","year":"2001","unstructured":"Avigdor A, Raanani P, Levi I, Hardan I, Ben-Bassat I: Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma. Leuk Lymphoma. 2001, 42: 683-687.","journal-title":"Leuk Lymphoma"},{"key":"2926_CR12","first-page":"539","volume":"124","author":"O Bairey","year":"1993","unstructured":"Bairey O, Huminer D, Blickstein D, Sandbank Y, Shaklai M: Relapse of multiple myeloma in extramedullary sites. Harefuah. 1993, 124: 539-541. 600","journal-title":"Harefuah"},{"key":"2926_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000041069","volume":"104","author":"T Iwasaki","year":"2000","unstructured":"Iwasaki T, Hamano T, Ogata A, Hashimoto N, Kakishita E: IgD multiple myeloma preceding the development of extensive extramedullary disease without medullary involvement. Acta Haematol. 2000, 104: 42-45.","journal-title":"Acta Haematol"},{"key":"2926_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1365-2230.2002.01039.x","volume":"27","author":"A Ah-Weng","year":"2002","unstructured":"Ah-Weng A, Charles-Holmes R, Rose P, Basu S, Marsden JR, Sanders DS: Multiple cutaneous plasmacytomas following an autologous peripheral stem cell transplant. Clin Exp Dermatol. 2002, 27: 293-295.","journal-title":"Clin Exp Dermatol"},{"key":"2926_CR15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ajh.21195","volume":"83","author":"A Candoni","year":"2008","unstructured":"Candoni A, Simeone E, Fanin R: Extramedullary progression of multiple myeloma under thalidomide therapy despite concomitant response of medullary disease. Am J Hematol. 2008, 83: 680-681.","journal-title":"Am J Hematol"},{"key":"2926_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-0609.2008.01087.x","volume":"81","author":"J Cerny","year":"2008","unstructured":"Cerny J, Fadare O, Hutchinson L, Wang SA: Clinicopathological features of extramedullary recurrence\/relapse of multiple myeloma. Eur J Haematol. 2008, 81: 65-69.","journal-title":"Eur J Haematol"},{"key":"2926_CR17","doi-asserted-by":"publisher","first-page":"7456","DOI":"10.4076\/1757-1626-2-7456","volume":"2","author":"DF Waterhouse","year":"2009","unstructured":"Waterhouse DF, Moloney GA, Gargoum FS, Hayden PS, O\u2019Gorman T: Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report. Cases J. 2009, 2: 7456-","journal-title":"Cases J"},{"key":"2926_CR18","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/j.leukres.2011.09.017","volume":"36","author":"A Gozzetti","year":"2012","unstructured":"Gozzetti A, Marchini E, Banchi B, Papini G, Defina M, Bocchia M, Lauria F: Extramedullary multifocal plasmacytoma relapse in multiple myeloma. Leuk Res. 2012, 36: e34-e36.","journal-title":"Leuk Res"},{"key":"2926_CR19","first-page":"278","volume":"90","author":"F Patriarca","year":"2005","unstructured":"Patriarca F, Prosdocimo S, Tomadini V, Vasciaveo A, Bruno B, Fanin R: Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. Haematologica. 2005, 90: 278-279.","journal-title":"Haematologica"},{"key":"2926_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00277-007-0401-8","volume":"87","author":"D Dytfeld","year":"2008","unstructured":"Dytfeld D, Matuszak M, Lewandowski K, Komarnicki M: Bortezomib in combination with thalidomide and dexamethasone \u2013 a successful treatment regimen in refractory extramedullary multiple myeloma. Ann Hematol. 2008, 87: 253-254.","journal-title":"Ann Hematol"},{"key":"2926_CR21","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV: Multiple myeloma. N Engl J Med. 2004, 351: 1860-1873.","journal-title":"N Engl J Med"},{"key":"2926_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood-2004-03-0833","volume":"105","author":"T Rasmussen","year":"2005","unstructured":"Rasmussen T, Kuehl M, Lodahl M, Johnsen HE, Dahl IM: Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood. 2005, 105: 317-323.","journal-title":"Blood"},{"key":"2926_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1365-2141.2007.06686.x","volume":"138","author":"L Trentin","year":"2007","unstructured":"Trentin L, Miorin M, Facco M, Baesso I, Carraro S, Cabrelle A, Maschio N, Bortoli M, Binotto G, Piazza F, Adami F, Zambello R, Agostini C, Semenzato G: Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity. Br J Haematol. 2007, 138: 594-602.","journal-title":"Br J Haematol"},{"key":"2926_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/annonc\/mdl129","volume":"18","author":"P Raanani","year":"2007","unstructured":"Raanani P, Shpilberg O, Ben-Bassat I: Extramedullary disease and targeted therapies for hematological malignancies \u2013 is the association real?. Ann Oncol. 2007, 18: 7-12.","journal-title":"Ann Oncol"},{"key":"2926_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10428190310001617231","volume":"45","author":"E Balleari","year":"2004","unstructured":"Balleari E, Ghio R, Falcone A, Musto P: Possible multiple myeloma dedifferentiation following thalidomide therapy: a report of four cases. Leuk Lymphoma. 2004, 45: 735-738.","journal-title":"Leuk Lymphoma"},{"key":"2926_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.seminhematol.2009.01.004","volume":"46","author":"E Kastritis","year":"2009","unstructured":"Kastritis E, Palumbo A, Dimopoulos MA: Treatment of relapsed\/refractory multiple myeloma. Semin Hematol. 2009, 46: 143-157.","journal-title":"Semin Hematol"},{"key":"2926_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/sj.leu.2404085","volume":"20","author":"JA Perez-Simon","year":"2006","unstructured":"Perez-Simon JA, Sureda A, Fernandez-Aviles F, Sampol A, Cabrera JR, Caballero D, Martino R, Petit J, Tomas JF, Moraleda JM, Alegre A, Ca\u00f1izo C, Brunet S, Rosi\u00f1ol L, Lahuerta J, D\u00edez-Mart\u00edn JL, Le\u00f3n A, Garc\u00eda A, Vazquez L, Sierra J, San Miguel JF: Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients. Leukemia. 2006, 20: 542-545.","journal-title":"Leukemia"},{"key":"2926_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.seminhematol.2009.02.003","volume":"46","author":"CS Mitsiades","year":"2009","unstructured":"Mitsiades CS, Hideshima T, Chauhan D, McMillin DW, Klippel S, Laubach JP, Munshi NC, Anderson KC, Richardson PG: Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib. Semin Hematol. 2009, 46: 166-175.","journal-title":"Semin Hematol"},{"key":"2926_CR29","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/leu.2009.174","volume":"23","author":"R Fonseca","year":"2009","unstructured":"Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BGM, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H: International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009, 23: 2210-2221.","journal-title":"Leukemia"},{"key":"2926_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.leukres.2009.01.010","volume":"33","author":"N Sheth","year":"2009","unstructured":"Sheth N, Yeung J, Chang H: p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma. Leuk Res. 2009, 33: 1357-1360.","journal-title":"Leuk Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-8-299\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T02:49:07Z","timestamp":1548125347000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-8-299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2926"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-8-299","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,8]]},"assertion":[{"value":"8 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"299"}}